Archive by Tag: infectious diseases

Thought Leader Select Supports Top Biopharma with KOL Strategies in Head and Neck Cancer

July 1, 2014 (CHAPEL HILL, NC) Thought Leader Select, a research and consulting firm serving the life sciences industries, has initiated new research and consulting work in support of a top global biopharmaceutical company’s developing portfolio of treatments for head and[...]

Top 10 Global Biopharmaceutical Company Tabs Thought Leader Select for Infectious Disease Partnership

April 26, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of an inter-disciplinary infectious disease engagement with a top 10 global biopharmaceutical company. The[...]

The Illuminating Value of a Key Opinion Leader Research Assessment: Validation versus Identification

During a recent client feedback survey interview, a pharmaceutical company executive defined Thought Leader Select’s value in this manner:  “We always think we know our physician key opinion leaders in a given therapeutic area.  Your company provides immense value not[...]

Fast Facts from Thought Leader Select–Advisory Board Service of Key Opinion Leaders

Key opinion leaders (KOLs) are health care leaders who make a high-impact footprint while advancing medical science. Thought Leader Select specializes in delivering objective, validated data on the skills and experiences of KOLs, so that pharmaceutical companies can seek their[...]